{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,24]],"date-time":"2025-12-24T18:55:56Z","timestamp":1766602556788,"version":"3.48.0"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,24]],"date-time":"2025-12-24T00:00:00Z","timestamp":1766534400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,12,24]],"date-time":"2025-12-24T00:00:00Z","timestamp":1766534400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Zhejiang Province Medical and Health Science and Technology Plan Project","award":["2024KY1706"],"award-info":[{"award-number":["2024KY1706"]}]},{"name":"Shaoxing Health Science and Technology Plan Project","award":["2022KY013"],"award-info":[{"award-number":["2022KY013"]}]},{"name":"Shaoxing People's Hospital Cardiovascular Surgery Research Team Project","award":["2021TD20"],"award-info":[{"award-number":["2021TD20"]}]},{"name":"Zhejiang Public Welfare Technology Application Research Project","award":["LTGD23H010002"],"award-info":[{"award-number":["LTGD23H010002"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Human Cell"],"DOI":"10.1007\/s13577-025-01337-1","type":"journal-article","created":{"date-parts":[[2025,12,24]],"date-time":"2025-12-24T18:51:05Z","timestamp":1766602265000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Exosomal miR-145-5p impairs neoadjuvant chemotherapy by suppressing TFRC-mediated macrophage iron uptake and driving M2 polarization in esophageal cancer"],"prefix":"10.1007","volume":"39","author":[{"given":"Jianfeng","family":"Xu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Deng","family":"Lei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peng","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuqi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhupeng","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiacheng","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weizhong","family":"Feng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junqing","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,12,24]]},"reference":[{"issue":"3","key":"1337_CR1","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3322\/caac.21834","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74(3):229\u201363. https:\/\/doi.org\/10.3322\/caac.21834.","journal-title":"CA Cancer J Clin"},{"key":"1337_CR2","doi-asserted-by":"publisher","first-page":"e074962","DOI":"10.1136\/bmj-2023-074962","volume":"385","author":"N Deboever","year":"2024","unstructured":"Deboever N, Jones CM, Yamashita K, Ajani JA, Hofstetter WL. Advances in diagnosis and management of cancer of the esophagus. BMJ. 2024;385:e074962. https:\/\/doi.org\/10.1136\/bmj-2023-074962.","journal-title":"BMJ"},{"issue":"3","key":"1337_CR3","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1007\/s11912-021-01153-4","volume":"24","author":"JK Waters","year":"2022","unstructured":"Waters JK, Reznik SI. Update on management of squamous cell esophageal cancer. Curr Oncol Rep. 2022;24(3):375\u201385. https:\/\/doi.org\/10.1007\/s11912-021-01153-4.","journal-title":"Curr Oncol Rep"},{"key":"1337_CR4","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15030765","author":"M Sheikh","year":"2023","unstructured":"Sheikh M, Roshandel G, McCormack V, Malekzadeh R. Current status and future prospects for esophageal cancer. Cancers. 2023. https:\/\/doi.org\/10.3390\/cancers15030765.","journal-title":"Cancers"},{"issue":"5","key":"1337_CR5","doi-asserted-by":"publisher","first-page":"535","DOI":"10.21147\/j.issn.1000-9604.2021.05.01","volume":"33","author":"J Li","year":"2021","unstructured":"Li J, Xu J, Zheng Y, Gao Y, He S, Li H, et al. Esophageal cancer: epidemiology, risk factors and screening. Chin J Cancer Res. 2021;33(5):535\u201347. https:\/\/doi.org\/10.21147\/j.issn.1000-9604.2021.05.01.","journal-title":"Chin J Cancer Res"},{"key":"1337_CR6","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202503223","author":"SJ Li","year":"2025","unstructured":"Li SJ, Liang ZR, Liu ZC, Luo XP, Li JY, Yu XM, et al. LIMK1 as a novel kinase of \u03b2-catenin promotes esophageal cancer metastasis by cooperating with CDK5. Adv Sci. 2025. https:\/\/doi.org\/10.1002\/advs.202503223.","journal-title":"Adv Sci"},{"issue":"23","key":"1337_CR7","doi-asserted-by":"publisher","first-page":"3236","DOI":"10.3748\/wjg.v26.i23.3236","volume":"26","author":"U Warnecke-Eberz","year":"2020","unstructured":"Warnecke-Eberz U, Plum P, Schweinsberg V, Drebber U, Bruns CJ, Muller DT, et al. Neoadjuvant chemoradiation changes podoplanin expression in esophageal cancer patients. World J Gastroenterol. 2020;26(23):3236\u201348. https:\/\/doi.org\/10.3748\/wjg.v26.i23.3236.","journal-title":"World J Gastroenterol"},{"key":"1337_CR8","doi-asserted-by":"publisher","first-page":"1478922","DOI":"10.3389\/fimmu.2024.1478922","volume":"15","author":"Z Qiu","year":"2024","unstructured":"Qiu Z, Li Z, Liu X, Zhang R, Li Y, Gao C, et al. From tumor microenvironment to emerging biomarkers: the reshaping of the esophageal squamous cell carcinoma tumor microenvironment by neoadjuvant chemotherapy combined with immunotherapy. Front Immunol. 2024;15:1478922. https:\/\/doi.org\/10.3389\/fimmu.2024.1478922.","journal-title":"Front Immunol"},{"key":"1337_CR9","doi-asserted-by":"publisher","first-page":"1108213","DOI":"10.3389\/fimmu.2023.1108213","volume":"14","author":"H Qin","year":"2023","unstructured":"Qin H, Liu F, Zhang Y, Liang Y, Mi Y, Yu F, et al. Comparison of neoadjuvant immunotherapy versus routine neoadjuvant therapy for patients with locally advanced esophageal cancer: a systematic review and meta-analysis. Front Immunol. 2023;14:1108213. https:\/\/doi.org\/10.3389\/fimmu.2023.1108213.","journal-title":"Front Immunol"},{"issue":"1","key":"1337_CR10","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.radonc.2016.05.009","volume":"120","author":"SE Heethuis","year":"2016","unstructured":"Heethuis SE, van Rossum PS, Lips IM, Goense L, Voncken FE, Reerink O, et al. Dynamic contrast-enhanced MRI for treatment response assessment in patients with oesophageal cancer receiving neoadjuvant chemoradiotherapy. Radiother Oncol. 2016;120(1):128\u201335. https:\/\/doi.org\/10.1016\/j.radonc.2016.05.009.","journal-title":"Radiother Oncol"},{"key":"1337_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2022.104371","author":"J Wen","year":"2022","unstructured":"Wen J, Fang S, Hu Y, Xi M, Weng Z, Pan C, et al. Impacts of neoadjuvant chemoradiotherapy on the immune landscape of esophageal squamous cell carcinoma. EBioMedicine. 2022. https:\/\/doi.org\/10.1016\/j.ebiom.2022.104371.","journal-title":"EBioMedicine"},{"issue":"4","key":"1337_CR12","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1111\/cas.14328","volume":"111","author":"K Yamamoto","year":"2020","unstructured":"Yamamoto K, Makino T, Sato E, Noma T, Urakawa S, Takeoka T, et al. Tumor-infiltrating M2 macrophage in pretreatment biopsy sample predicts response to chemotherapy and survival in esophageal cancer. Cancer Sci. 2020;111(4):1103\u201312. https:\/\/doi.org\/10.1111\/cas.14328.","journal-title":"Cancer Sci"},{"issue":"6","key":"1337_CR13","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1158\/1541-7786.Mcr-20-0917","volume":"19","author":"S Nakajima","year":"2021","unstructured":"Nakajima S, Mimura K, Saito K, Thar Min AK, Endo E, Yamada L, et al. Neoadjuvant chemotherapy induces IL34 signaling and promotes chemoresistance via tumor-associated macrophage polarization in esophageal squamous cell carcinoma. Mol Cancer Res. 2021;19(6):1085\u201395. https:\/\/doi.org\/10.1158\/1541-7786.Mcr-20-0917.","journal-title":"Mol Cancer Res"},{"issue":"1","key":"1337_CR14","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1186\/s13073-025-01465-1","volume":"17","author":"Y Gao","year":"2025","unstructured":"Gao Y, He S, Meng X, Zheng K, Cui H, Cheng Y, et al. Multi-omics analysis reveals immunosuppression in oesophageal squamous cell carcinoma induced by creatine accumulation and HK3 deficiency. Genome Med. 2025;17(1):44. https:\/\/doi.org\/10.1186\/s13073-025-01465-1.","journal-title":"Genome Med"},{"issue":"7","key":"1337_CR15","doi-asserted-by":"publisher","first-page":"e459","DOI":"10.1002\/ctm2.459","volume":"11","author":"Z Lu","year":"2021","unstructured":"Lu Z, Zheng S, Liu C, Wang X, Zhang G, Wang F, et al. S100A7 as a potential diagnostic and prognostic biomarker of esophageal squamous cell carcinoma promotes M2 macrophage infiltration and angiogenesis. Clin Transl Med. 2021;11(7):e459. https:\/\/doi.org\/10.1002\/ctm2.459.","journal-title":"Clin Transl Med"},{"issue":"1","key":"1337_CR16","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/s12967-022-03863-0","volume":"21","author":"K Yang","year":"2023","unstructured":"Yang K, Xie Y, Xue L, Li F, Luo C, Liang W, et al. M2 tumor-associated macrophage mediates the maintenance of stemness to promote cisplatin resistance by secreting TGF-\u03b21 in esophageal squamous cell carcinoma. J Transl Med. 2023;21(1):26. https:\/\/doi.org\/10.1186\/s12967-022-03863-0.","journal-title":"J Transl Med"},{"issue":"1","key":"1337_CR17","doi-asserted-by":"publisher","first-page":"113963","DOI":"10.1016\/j.yexcr.2024.113963","volume":"439","author":"J Yuan","year":"2024","unstructured":"Yuan J, Hou B, Guo K, Zhu J, Xiao H. Tumor-derived exosomal hyaluronidase 1 induced M2 macrophage polarization and promoted esophageal cancer progression. Exp Cell Res. 2024;439(1):113963. https:\/\/doi.org\/10.1016\/j.yexcr.2024.113963.","journal-title":"Exp Cell Res"},{"key":"1337_CR18","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25116082","author":"LR Gao","year":"2024","unstructured":"Gao LR, Zhang J, Huang N, Deng W, Ni W, Xiao Z, et al. Tumor-derived exosomal miR-143-3p induces macrophage M2 polarization to cause radiation resistance in locally advanced esophageal squamous cell carcinoma. Int J Mol Sci. 2024. https:\/\/doi.org\/10.3390\/ijms25116082.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"1337_CR19","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1186\/s13046-023-02871-2","volume":"42","author":"X Qiao","year":"2023","unstructured":"Qiao X, Cheng Z, Xue K, Xiong C, Zheng Z, Jin X, et al. Tumor-associated macrophage-derived exosomes LINC01592 induce the immune escape of esophageal cancer by decreasing MHC-I surface expression. J Exp Clin Cancer Res CR. 2023;42(1):289. https:\/\/doi.org\/10.1186\/s13046-023-02871-2.","journal-title":"J Exp Clin Cancer Res CR"},{"issue":"3","key":"1337_CR20","doi-asserted-by":"publisher","first-page":"367","DOI":"10.3233\/cbm-160575","volume":"16","author":"N Nouraee","year":"2016","unstructured":"Nouraee N, Khazaei S, Vasei M, Razavipour SF, Sadeghizadeh M, Mowla SJ. Micrornas contribution in tumor microenvironment of esophageal cancer. Cancer Biomark. 2016;16(3):367\u201376. https:\/\/doi.org\/10.3233\/cbm-160575.","journal-title":"Cancer Biomark"},{"issue":"1","key":"1337_CR21","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1186\/s12967-021-03034-7","volume":"19","author":"JL Sun","year":"2021","unstructured":"Sun JL, Zhang NP, Xu RC, Zhang GC, Liu ZY, Abuduwaili W, et al. Tumor cell-imposed iron restriction drives immunosuppressive polarization of tumor-associated macrophages. J Transl Med. 2021;19(1):347. https:\/\/doi.org\/10.1186\/s12967-021-03034-7.","journal-title":"J Transl Med"},{"key":"1337_CR22","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.bcmd.2016.07.006","volume":"61","author":"R Agoro","year":"2016","unstructured":"Agoro R, Mura C. Inflammation-induced up-regulation of hepcidin and down-regulation of ferroportin transcription are dependent on macrophage polarization. Blood Cells Mol Dis. 2016;61:16\u201325. https:\/\/doi.org\/10.1016\/j.bcmd.2016.07.006.","journal-title":"Blood Cells Mol Dis"},{"issue":"5","key":"1337_CR23","doi-asserted-by":"publisher","first-page":"e0196921","DOI":"10.1371\/journal.pone.0196921","volume":"13","author":"R Agoro","year":"2018","unstructured":"Agoro R, Taleb M, Quesniaux VFJ, Mura C. Cell iron status influences macrophage polarization. PLoS ONE. 2018;13(5):e0196921. https:\/\/doi.org\/10.1371\/journal.pone.0196921.","journal-title":"PLoS ONE"},{"issue":"10","key":"1337_CR24","doi-asserted-by":"publisher","first-page":"2674","DOI":"10.1039\/c7sc04853j","volume":"9","author":"P Zhao","year":"2018","unstructured":"Zhao P, Wang Y, Kang X, Wu A, Yin W, Tang Y, et al. Dual-targeting biomimetic delivery for anti-glioma activity via remodeling the tumor microenvironment and directing macrophage-mediated immunotherapy. Chem Sci. 2018;9(10):2674\u201389. https:\/\/doi.org\/10.1039\/c7sc04853j.","journal-title":"Chem Sci"},{"key":"1337_CR25","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.89903","author":"Z Xu","year":"2024","unstructured":"Xu Z, Wang Z, Wang L, Qi YB. Essential function of transmembrane transcription factor MYRF in promoting transcription of miRNA lin-4 during C. elegans development. Elife. 2024. https:\/\/doi.org\/10.7554\/eLife.89903.","journal-title":"Elife"},{"issue":"6","key":"1337_CR26","doi-asserted-by":"publisher","first-page":"3833","DOI":"10.3892\/mmr.2017.6479","volume":"15","author":"Y Wang","year":"2017","unstructured":"Wang Y, Zhang J, Zhao W, Wang D, Ma W, Shang S, et al. Microrna expression in esophageal squamous cell carcinoma: novel diagnostic and prognostic biomarkers. Mol Med Rep. 2017;15(6):3833\u20139. https:\/\/doi.org\/10.3892\/mmr.2017.6479.","journal-title":"Mol Med Rep"},{"key":"1337_CR27","doi-asserted-by":"publisher","first-page":"6692544","DOI":"10.1155\/2021\/6692544","volume":"2021","author":"S Fan","year":"2021","unstructured":"Fan S, Chen P, Li S. Mir-145-5p inhibits the proliferation, migration, and invasion of esophageal carcinoma cells by targeting ABRACL. BioMed Res Int. 2021;2021:6692544. https:\/\/doi.org\/10.1155\/2021\/6692544.","journal-title":"BioMed Res Int"},{"issue":"7","key":"1337_CR28","doi-asserted-by":"publisher","first-page":"2493","DOI":"10.21037\/jtd-22-294","volume":"14","author":"J Lin","year":"2022","unstructured":"Lin J, Wu S, Zhu K, Zhang J, Shi X, Shen J, et al. The role of mir-145-5p in esophageal squamous cell carcinoma tumor-associated macrophages and selection of immunochemotherapy. J Thorac Dis. 2022;14(7):2493\u2013510. https:\/\/doi.org\/10.21037\/jtd-22-294.","journal-title":"J Thorac Dis"},{"issue":"23","key":"1337_CR29","doi-asserted-by":"publisher","first-page":"6480","DOI":"10.1158\/0008-5472.Can-17-0994","volume":"77","author":"CF Ruivo","year":"2017","unstructured":"Ruivo CF, Adem B, Silva M, Melo SA. The biology of cancer exosomes: insights and new perspectives. Cancer Res. 2017;77(23):6480\u20138. https:\/\/doi.org\/10.1158\/0008-5472.Can-17-0994.","journal-title":"Cancer Res"},{"issue":"9","key":"1337_CR30","doi-asserted-by":"publisher","first-page":"e464","DOI":"10.1002\/ctm2.464","volume":"11","author":"L Zhang","year":"2021","unstructured":"Zhang L, Wang X, Li Y, Han J, Gao X, Li S, et al. C-Myb facilitates immune escape of esophageal adenocarcinoma cells through the miR-145-5p\/SPOP\/PD-L1 axis. Clin Transl Med. 2021;11(9):e464. https:\/\/doi.org\/10.1002\/ctm2.464.","journal-title":"Clin Transl Med"},{"issue":"10","key":"1337_CR31","doi-asserted-by":"publisher","first-page":"107753","DOI":"10.1016\/j.jbc.2024.107753","volume":"300","author":"A Sharma","year":"2024","unstructured":"Sharma A, Vikramdeo KS, Sudan SK, Anand S, Deshmukh SK, Singh AP, et al. Cortisol affects macrophage polarization by inducing miR-143\/145 cluster to reprogram glucose metabolism and by promoting TCA cycle anaplerosis. J Biol Chem. 2024;300(10):107753. https:\/\/doi.org\/10.1016\/j.jbc.2024.107753.","journal-title":"J Biol Chem"},{"key":"1337_CR32","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23116312","author":"A Pace","year":"2022","unstructured":"Pace A, Scirocchi F, Napoletano C, Zizzari IG, D\u2019Angelo L, Santoro A, et al. Glycan-lectin interactions as novel immunosuppression drivers in glioblastoma. Int J Mol Sci. 2022. https:\/\/doi.org\/10.3390\/ijms23116312.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"1337_CR33","doi-asserted-by":"publisher","first-page":"114884","DOI":"10.1016\/j.ejmech.2022.114884","volume":"245","author":"J Wen","year":"2023","unstructured":"Wen J, Wang S, Guo R, Liu D. CSF1R inhibitors are emerging immunotherapeutic drugs for cancer treatment. Eur J Med Chem. 2023;245(1):114884. https:\/\/doi.org\/10.1016\/j.ejmech.2022.114884.","journal-title":"Eur J Med Chem"},{"issue":"19","key":"1337_CR34","doi-asserted-by":"publisher","first-page":"1799","DOI":"10.1093\/eurheartj\/ehac094","volume":"43","author":"MK Georgakis","year":"2022","unstructured":"Georgakis MK, Bernhagen J, Heitman LH, Weber C, Dichgans M. Targeting the CCL2-CCR2 axis for atheroprotection. Eur Heart J. 2022;43(19):1799\u2013808. https:\/\/doi.org\/10.1093\/eurheartj\/ehac094.","journal-title":"Eur Heart J"},{"issue":"38","key":"1337_CR35","doi-asserted-by":"publisher","first-page":"5764","DOI":"10.1038\/s41388-021-01988-y","volume":"40","author":"S Du","year":"2021","unstructured":"Du S, Yang Z, Lu X, Yousuf S, Zhao M, Li W, et al. Anoikis resistant gastric cancer cells promote angiogenesis and peritoneal metastasis through C\/EBP\u03b2-mediated PDGFB autocrine and paracrine signaling. Oncogene. 2021;40(38):5764\u201379. https:\/\/doi.org\/10.1038\/s41388-021-01988-y.","journal-title":"Oncogene"},{"issue":"15","key":"1337_CR36","doi-asserted-by":"publisher","first-page":"1490","DOI":"10.18632\/oncotarget.28025","volume":"12","author":"M Khushman","year":"2021","unstructured":"Khushman M, Prodduturvar P, Mneimneh W, Zotto VD, Akbar S, Grimm L, et al. The impact of neoadjuvant concurrent chemoradiation on exosomal markers (CD63 and CD9) expression and their prognostic significance in patients with rectal adenocarcinoma. Oncotarget. 2021;12(15):1490\u20138. https:\/\/doi.org\/10.18632\/oncotarget.28025.","journal-title":"Oncotarget"},{"key":"1337_CR37","doi-asserted-by":"publisher","first-page":"923043","DOI":"10.3389\/fonc.2022.923043","volume":"12","author":"CJ Greene","year":"2022","unstructured":"Greene CJ, Attwood K, Sharma NJ, Balderman B, Deng R, Muhitch JB, et al. Iron accumulation typifies renal cell carcinoma tumorigenesis but abates with pathological progression, sarcomatoid dedifferentiation, and metastasis. Front Oncol. 2022;12:923043. https:\/\/doi.org\/10.3389\/fonc.2022.923043.","journal-title":"Front Oncol"},{"issue":"6","key":"1337_CR38","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1007\/s10147-025-02769-3","volume":"30","author":"S Kobayashi","year":"2025","unstructured":"Kobayashi S, Yamada D, Doki Y, Eguchi H. Revisiting resectability of biliary tract cancers, in the triplet drug therapy era with immune checkpoint inhibitors. Int J Clin Oncol. 2025;30(6):1060\u20138. https:\/\/doi.org\/10.1007\/s10147-025-02769-3.","journal-title":"Int J Clin Oncol"},{"issue":"1","key":"1337_CR39","first-page":"22","volume":"95","author":"MW Short","year":"2017","unstructured":"Short MW, Burgers KG, Fry VT. Esophageal cancer. Am Fam Physician. 2017;95(1):22\u20138.","journal-title":"Am Fam Physician"},{"issue":"11","key":"1337_CR40","doi-asserted-by":"publisher","first-page":"3379","DOI":"10.1016\/j.apsb.2021.03.008","volume":"11","author":"S He","year":"2021","unstructured":"He S, Xu J, Liu X, Zhen Y. Advances and challenges in the treatment of esophageal cancer. Acta Pharm Sin B. 2021;11(11):3379\u201392. https:\/\/doi.org\/10.1016\/j.apsb.2021.03.008.","journal-title":"Acta Pharm Sin B"},{"issue":"1","key":"1337_CR41","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/s12943-021-01313-x","volume":"20","author":"S Mohapatra","year":"2021","unstructured":"Mohapatra S, Pioppini C, Ozpolat B, Calin GA. Non-coding RNAs regulation of macrophage polarization in cancer. Mol Cancer. 2021;20(1):24. https:\/\/doi.org\/10.1186\/s12943-021-01313-x.","journal-title":"Mol Cancer"},{"issue":"18","key":"1337_CR42","doi-asserted-by":"publisher","first-page":"15984","DOI":"10.18632\/oncotarget.3762","volume":"6","author":"W Ma","year":"2015","unstructured":"Ma W, Yu J, Qi X, Liang L, Zhang Y, Ding Y, et al. Radiation-induced microrna-622 causes radioresistance in colorectal cancer cells by down-regulating Rb. Oncotarget. 2015;6(18):15984\u201394. https:\/\/doi.org\/10.18632\/oncotarget.3762.","journal-title":"Oncotarget"},{"issue":"1","key":"1337_CR43","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1186\/s10020-025-01200-x","volume":"31","author":"M Wang","year":"2025","unstructured":"Wang M, Chen Y, Xu B, Zhu X, Mou J, Xie J, et al. Recent advances in the roles of extracellular vesicles in cardiovascular diseases: pathophysiological mechanisms, biomarkers, and cell-free therapeutic strategy. Mol Med (Cambridge, Mass). 2025;31(1):169. https:\/\/doi.org\/10.1186\/s10020-025-01200-x.","journal-title":"Mol Med (Cambridge, Mass)"},{"key":"1337_CR44","doi-asserted-by":"publisher","DOI":"10.3390\/ijms18091833","author":"LL Mei","year":"2017","unstructured":"Mei LL, Wang WJ, Qiu YT, Xie XF, Bai J, Shi ZZ. miR-145-5p suppresses tumor cell migration, invasion and epithelial to mesenchymal transition by regulating the Sp1\/NF-\u03baB signaling pathway in esophageal squamous cell carcinoma. Int J Mol Sci. 2017. https:\/\/doi.org\/10.3390\/ijms18091833.","journal-title":"Int J Mol Sci"}],"container-title":["Human Cell"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13577-025-01337-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13577-025-01337-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13577-025-01337-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,24]],"date-time":"2025-12-24T18:51:05Z","timestamp":1766602265000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13577-025-01337-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,24]]},"references-count":44,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,1]]}},"alternative-id":["1337"],"URL":"https:\/\/doi.org\/10.1007\/s13577-025-01337-1","relation":{},"ISSN":["1749-0774"],"issn-type":[{"value":"1749-0774","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,24]]},"assertion":[{"value":"9 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no competing interests to declare that are relevant to the content of this article.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The animal experiments in this study were conducted following the ARRIVE guidelines and the \"Guiding Principles in the Care and Use of Animals\" (China) and approved by the Ethics Committee of Shaoxing People\u2019s Hospital (Approval number: 2024Z014). The study was performed in accordance with the ethical standards as laid down in the 1964 Declaration of Helsinki and its later amendments or comparable ethical standards. The EC clinical samples were collected from patients with informed consent and ethical guidelines approved by the Academic Ethics Committee of Shaoxing People\u2019s Hospital (Approval number: IEC-K-AF-070\u20131.2).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}],"article-number":"27"}}